Rx information for visually impaired
Executive Summary
FDA is seeking comments on the accessibility of pharmaceutical information to the visually impaired for a study mandated by the Medicare Modernization Act. In a May 20 Federal Register notice, the agency asks "how do people who are blind and visually impaired currently get their drug information"; "what assistive technologies are currently used"; and "how can essential drug information be effectively communicated to people who are blind and visually impaired." Comments are due by June 21...